Baader Bank Aktiengesellschaft’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio NBSE Stock Details NBSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-16,089	Closed	-$4.95K	–	557
2024 Q2	$4.95K	Buy	+16,089	New	+$6.7K	﹤0.01%	407

Baader Bank Aktiengesellschaft's NBSE Position: Q3 2024 in Review

Baader Bank Aktiengesellschaft sold out of NeuBase Therapeutics, Inc. Common Stock (NBSE) in Q3 2024, closing a stake of 16,089 shares — an estimated $4.95K sold.

Baader Bank Aktiengesellschaft first reported a position in NBSE in Q2 2024 and held it in 1 quarter. The position peaked at $4.95K in Q2 2024. 1 fund tracked by Wall St. Rank holds NBSE as of Q3 2024.

Baader Bank Aktiengesellschaft reported no remaining NeuBase Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Baader Bank Aktiengesellschaft sold 16,089 NeuBase Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $4.95K.
Baader Bank Aktiengesellschaft first reported a position in NeuBase Therapeutics, Inc. Common Stock in Q2 2024 and held it in 1 quarter.
Baader Bank Aktiengesellschaft's NeuBase Therapeutics, Inc. Common Stock position peaked at $4.95K in Q2 2024.
1 fund tracked by Wall St. Rank held NeuBase Therapeutics, Inc. Common Stock as of Q3 2024.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q3 2024, filed 29 Oct 2024.